Heyuan Biotech warmly congratulates Rongrui Pharmaceutical’s ﬁrst oncolytic virus OVV-01 on obtaining the dual IND license of United States FDA [Google translation]

OVV-01 - Joint Biosci, Beijing Boren Hospital

Sep 26, 2024